Bone mass measurement and bone metabolism in rheumatoid arthritis: A review

Revmatologiia

Volumn 35, Issue 4, 1996, Pages 309-322

  Deodhar, A A ^a   Woolf, A D ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Bone biochemistry; Bone density; Bone histomorphometry; Corticosteroids; Cytokines; Fractures; Hand bone densitometry; Osteoporosis; Radiogrammetry; Rheumatoid arthritis

Indexed keywords

BIOCHEMICAL MARKER; CORTICOSTEROID; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCALCIN; TUMOR NECROSIS FACTOR ALPHA;

BONE ATROPHY; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; DENSITOMETRY; DISEASE COURSE; HAND; HUMAN; MORPHOMETRICS; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; FRACTURES, BONE; HUMANS; OSTEOPOROSIS;

EID: 0029868840     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.4.309     Document Type: Review

References (88)

1. Barwell R. Diseases of the joints. London: Hardwicke, 1865.
2. Kennedy AC, Lindsay R. Bone involvement in rheumatoid arthritis. Clin Rheum Dis 1977;3:403-20.
3. Brook A, Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis 1977;36:71-3.
4. Als OS, Gotfredsen A, Riss VJ, Christianson C. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis. Ann Rheum Dis 1985;44:406-11.
5. Sambrook PN, Eisman JA, Champion JD, Pocock NA, Yeates mg, Ebrl S. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis 1986; 45:950-3.
6. Sambrook PN, Eisman JA, Champion JD, Yeates MD, Pocock NA, Ebrl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
7. Sambrook PN, Cohen ML, Eisman JA, Pocock MA, Champion JD, Yeates MG. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989;48:535-8.
8. Reid DM, Kennedy NSJ, Smith MA, Nicholl J, Tothill P, Nuki G. Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 1986;5:372-8.
9. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in post menopausal patients with rheumatoid arthritis. Ann Rheum Dis 1986;45:852-7.
10. Cooper C, Poll V, Mclaren M, Daunt S, O'Cowley MID. Alterations in appendicular skeletal mass in patients with rheumatoid, psoriatic and osteoarthropathy. Ann Rheum Dis 1988;47:481-4.
11. O'Malley M, Kenrick AJ, Sartoris DJ et al. Axial bone density in rheumatoid arthritis: comparison of dual energy projection radiography and dual photon absorptiometry. Radiology 1989;70:501-5.
12. Butler RC, Davey MW, Worsfield M, Sharp CA. Bone mineral content in patients with rheumatoid arthritis: relationship to low dose steroid therapy. Br J Rheumatol 1991;30:86-90.
13. Laan RFJN, van Riel PLCM, van de Putte LBA. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:826-32.
14. Laan RFJM, Buijs WCAM, Verbeek ALM et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
15. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 1991;20:256-72.
16. Kaplan AP. Kinins and bone resorption in rheumatic disease. Arthritis Rheum 1987;30:589-92.
17. Alwan WH, Dieppe PA, Elson CJ, Bradfield JWB. Bone resorbing activity in synovial fluids in destructive osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 1988;47:198-205.
18. Eastgate JA, Wood NC, Di Giovine FS, Symons JA, Grinlinton FM, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988;ii:706-9.
19. Fogleman I. Rheumatoid arthritis and osteoporosis. Br J Rheumatol 1986;25:240-2.
20. Woolf AD. Osteoporosis in rheumatoid arthritis - the clinical view point. Br J Rheumatol 1991;30:82-4.
21. Laan RFJM, van Riel PLCM, van Earning LJTh, Lemmens JAM, Ruijs SHJ, van de Putte LBA. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisolone therapy. Br J Rheumatol 1992;31:91-6.
22. Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52:582-5.
23. Sambrook PN, Ansell BM, Foster S et al. Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Ann Rheum Dis 1985;44:575-9.
24. Gevers G, Davos P, De Roo M, Dequeker J. Increased levels of osteocalcin (serum bone GLA protein) in rheumatoid arthritis. Br J Rheumatol 1986;25:260-2.
25. Weisman MH, Orth RW, Catherwood BD, Manolagras SC, Deftos LJ. Measures of bone loss in rheumatoid arthritis. Arch Intern Med 1986;146:701-4.
26. Seibel MJ, Duncan A, Robins SP. Urinary hydroxypyridinium cross-links provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989; 16:964-70.
27. Peitschmann P, Machold KP, Wolosczuk W, Smolen JS. Serum osteocalcin concentration in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48: 654-7.
28. Shimizo S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985;28:25-31.
29. Van Soesbergen RM, Lips P, Van den Ende A, Van der Korst JK. Bone metabolism in rheumatoid arthritis compared with postmenopausal osteoporosis. Ann Rheum Dis 1986;45:149-55.
30. Mellish RWE, O'Sullivan MM, Garrahan NJ, Compston JE. Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1987;46:830-6.
31. Compston JE, Vedi S, Croucher PI, Garrahan NJ, O'Sullivan MM. Bone turnover in non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1994;53:163-6.
32. Hooyman JR, Melton LJ, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis: A population based study. Arthritis Rheum 1984;27:1353-61.
33. Bhalla AK, Shenstone B. Bone densitometry measurements in early inflammatory disease. Baillière's Clin Rheumatol 1992;6:405-14.
34. Wahner HW, Fogleman I. In: The evaluation of osteoporosis: Dual energy x-ray absorptiometry in clinical practice. London: Martin Dunitz, 1994:178.
35. Eastell R. Biochemical markers. Spine 1994;8:155-70.
36. Scott DL, Coulton BL, Bacon PA, Popert AJ. Methods of x-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol 1985;24:31-9.
37. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706-20.
38. Sharp JT, Young D, Bluhm GB et al. How many joints in the hand and wrists should be included in a score of radiological abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
39. Larsen A, Dale K, Elk M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
40. Bluhm GB, Smith DW, Mikulashek WM. A radiologic method of assessment of bone and joint destruction in rheumatoid arthritis. Henry Ford Hosp Med J 1983;31: 152-61.
41. Brower AC. Use of radiographs to measure the course of rheumatoid arthritis: The gold standard versus fool's gold. Arthritis Rheum 1990;33:316-23.
42. Burnett E, Nordin BEC. The radiological diagnosis of osteoporosis: a new approach. Clin Radiol 1960;11: 166-74.
43. Dequeker J. Quantitative radiology: Radiogrammetry of cortical bone. Br J Radiol 1976;49:912-20.
44. Bloom RA. A comparative estimation of the combined cortical thickness of various bone sites. Skeletal Radiol 1980;5:167-70.
45. Kalla AA, Meyers OL, Parkyn ND, Kotze TJvW. Osteoporosis screening - radiogrammetry revisited. Br J Rheumatol 1989;28:511-7.
46. Kalla AA, Meyers OL, Charlton D et al. Increased metacarpal bone mass following eighteen months of slow acting anti rheumatic drugs for rheumatoid arthritis. Br J Rheumatol 1991;30:91-100.
47. Resnick D. Diagnostic techniques. In: Resnick D, ed. Bone and joint imaging. Philadelphia: W B Saunders, 1989:85-136.
48. Brower AC. Rheumatoid arthritis: Imaging. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1994;3:6.1-6.8.
49. Peel NFA, Spittlehouse AJ, Bax DE, Eastell R. Bone mineral density of the hand in rheumatoid arthritis. Arthritis Rheum 1994;37:983-91.
50. Als OS, Christiansen C, Hellesen C. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment. Clin Rheumatol 1984;3: 201-8.
51. Sambrook PN, Shawe D, Hesp R et al. Rapid periarticular bone loss in rheumatoid arthritis: Possible promotion by normal circulating concentrations of parathyroid hormone or calcitriol (1,25-dihydroxyvitamin D3). Arthritis Rheum 1990;33:615-22.
52. Flemming A, Crown JM, Corbett M. Early rheumatoid disease: 1. Onset. Ann Rheum Dis 1976;35:357-9.
53. Fries JF, Bloch DA, Sharp JT et al. Assessment of radiological progression in rheumatoid arthritis: A randomised controlled trial. Arthritis Rheum 1986;29:1-9.
54. Pye DW, Law A. The measurement of total hand bone mineral by QDR. In: Ring EFJ, ed. Current research in osteoporosis and bone mineral measurement. London: BIR, 1990:20.
55. Harley ML, Deodhar AA, Sharp C, Nicholson P, Woolf AD. Three methods of assessing hand bone mineral content: a comparison of accuracy, reproducibility and ease of use. In: Ring EFJ, Elvins DM, Bhalla AK, eds. Current research in osteoporosis and bone mineral measurement. London: BIR, 1994;3:71.
56. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis. Ann Rheum Dis 1994;53:685-90.
57. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Longitudinal study of hand bone densitometry in rheumatoid arthritis. Arthritis Rheum 1995;38:1204-10.
58. Reid DM, Kennedy NSJ, Smith MA, Tothill P, Nuki G. Total body calcium in rheumatoid arthritis: the effects of disease activity and corticosteroid treatment. Br Med J 1982;285:330-2.
59. Reid DM, Kennedy NSJ, Smith MA et al. Bone loss in rheumatoid arthritis in primary generalised osteoarthrosis: Effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements. Br J Rheumatol 1986; 25:253-9.
60. Laan RFJM, van de Putte LBA, van Reil PLCM, van Erning LJThO, van't Hof MA, Lemmens AM. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993;119:963-8.
61. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
62. Shenstone BD, Mahmoud A, Woodward R et al. Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 1994;33:541-5.
63. Adachi JD. Markers of bone turnover in rheumatoid arthritis. J Rheumatol 1991;18:1119-20.
64. Marhoffer W, Schatz H, Stracke H, Ullmann J, Schmidt K, Federlin K. Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis. J Rheumatol 1991;18: 1158-62.
65. Kollerup G, Hansen M, Horslev-Petersen K. Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheumatol 1994;33:816-21.
66. Peel NFA, Eastell R, Russell G. Markers of bone and collagen breakdown in early inflammatory arthritis. Baillère's Clin Rheumatol 1992;6:351-72.
67. Ekenstam EA, Ljunghall S, Hallgren R. Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Ann Rheum Dis 1986;45:484-90.
68. Magaro M, Altomonte L, Mirone L, Zoli A, Corvino G. Bone GLA protein (BGP) levels and bone turnover in rheumatoid arthritis. Br J Rheumatol 1989;28:207-11.
69. Robins SP, Stewart P, Astbury C, Bird H. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann Rheum Dis 1986;45:969-73.
70. Black D, Marabani M, Sturrock RD, Robins SP. Urinary excretion of the hydroxypyridinium cross-links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-4.
71. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium cross-links correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53: 14-7.
72. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Mineral 1990;8:87-96.
73. Wordsworth BP, Vipond S, Woods CG, Mowat AG. Metabolic bone disease among in-patients with rheumatoid arthritis. Br J Rheumatol 1984;23:251-7.
74. Compston JE, Vedi S, Mellish RWE, Croucher P, O'Sullivan MM. Reduced bone formation in non-steroid treated patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:483-7.
75. Als OS, Gotfredsen A, Christiansen C. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients: Influence of menopausal state. Arthritis Rheum 1985;28:369-75.
76. Davis MJ, Dawes PT, Fowler PD et al. Comparison and evaluation of a disease activity index for use in patients with RA. Br J Rheumatol 1990;29:111-5.
77. Kannel WB, Sorlie P. Some health benefits of physical activity: The Framingham study. Arch Intern Med 1979-139:857-61.
78. Tinetti ME, Speechley M, Guiter SF. Risk factors for falls among elderly persons living in the community N Engl J Med 1988;319:1701-7.
79. Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18: 804-8.
80. Isdale AH. Stress fractures of the pubic rami in rheumatoid arthritis. Ann Rheum Dis 1993;52:681-4.
81. Peh WCG, Gough AKS, Sheeran T, Evans NS, Emery P. Pelvic insufficiency fractures in rheumatoid arthritis. Br J Rheumatol 1993;32:319-24.
82. Fam AG, Shuckett R, McGrllivray DC, Little AH. Stress fractures in rheumatoid arthritis. J Rheumatol 1983;10:722-6.
83. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. J Bone Joint Surg 1984;60A:602-7.
84. May KP, West SG, McDermott MT, Huffer WE. The effect of low dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 1994;37: 201-6.
85. Bologna C, Edno L, Anaya JM et al. Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients. Arthritis Rheum 1994;37:1770-3.
86. Hall GM, Daniels M, Doyle DV, Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994;37:1499-505.
87. Van den Brink HR, Lems WF, van Everdingen AA, Bijlsma JWJ. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis 1993;52:302-5.
88. Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BAC, Breedveld FC. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: A double blind placebo controlled study. J Rheumatol 1994;21:2016-20.